NEWS & EVENTS

News

JointPoint, Inc. Signs Exclusive Agreement with DePuy Synthes to Co-Market JointPoint’s Non-Invasive Computer Navigation System for Hip Replacement

Hip Navigation System Facilitates Precise Intraoperative Analysis of Implant Selection and Positioning During Surgery

OneTrial


09/19/2017 -- JointPoint, Inc., providers of non-invasive computer navigation, preoperative digital templating, case planning, and intra-operative feedback, is announcing that it has signed an exclusive agreement with DePuy Synthes to co-market its proprietary software platform. JointPoint™ integrates easily into the Direct Anterior Approach hip replacement technique.

"With over 1,000 cases completed over the last several months, surgeons are enjoying the benefits of JointPoint’s non-invasive hip navigation," said Noah Wollowick, President and Co-Founder of JointPoint. "We are excited to solidify this co-marketing agreement with DePuy Synthes, a worldwide leader in orthopaedics, to gain better access to surgeons across the country that want to use our innovative technology,"

JointPoint’s intraoperative software streamlines fluoroscopic use while providing the surgeon significant data on cup position, leg length and offset. Additionally, JointPoint’s OneTrial™ technology incorporates implant specific data that has the potential to reduce trialing during surgery.

"I used to rely on multiple fluoroscopic images and trials to confirm a patient's leg length and offset," said Dr. Charles Decook, MD. "With the OneTrial™ technique from JointPoint, I am able to trial and shoot one fluoroscopic image, that is it. It tells me my offset and leg length and I am able to clearly pick the neck and head that works best for that patient. It has not only made me more efficient but also more accurate. I wouldn't even think of interpreting a fluoroscopic image now without JointPoint."

Adding the JointPoint software to a surgeon’s protocol may help reduce leg length discrepancy and complications related to inaccurate cup placement and final implant selection – two of the most important considerations in hip replacement surgery – by providing pre-surgical digital templating and real-time, data-driven surgical decision making in the operating room.

JointPoint’s navigation system minimizes adoption challenges of the anterior approach surgical method for hip replacement by providing cup position, leg length and offset data for a surgeon using as few as 3 radiographic images.

"One of the major benefits of anterior approach hip replacement is the power of intraoperative fluoroscopy and its ability to improve implant positioning, something all surgeons strive for consistently", said Andrew J. Cooper, M.D., JointPoint’s Chief Medical Officer and Co-Founder. "JointPoint harnesses the potential of fluoroscopy and allows surgeon to meet this goal efficiently with minimal images."

About JointPoint, Inc.

JointPoint, Inc. develops and markets software-driven medical technology for orthopaedics. The JointPoint™ software solution and OneTrial™ technology is a completely non-invasive navigation system for hip replacement surgery that provides intraoperative data and guides component selection while also optimizing efficiency within a surgical workflow. For more information, visit https://www.jointpoint.com

JointPoint Version 3.0

JointPoint releases version 3.0 to enhance user guidance and navigational functionality.

JointPoint Software-Only Navigation for DAA Hip Replacement Receives FDA 510(k) Clearance

JointPoint, Inc. announced today that its product has received 510(k) clearance as a Class II medical device from the U.S. Food and Drug Administration JointPoint is a software only navigation system for use in minimally invasive hip replacement surgeries such as direct anterior approach ("DAA").

The system provides a surgeon with intraoperative leg length, offset, and cup positioning data. It also features technology that guides a user in stem and head selection during surgery, with the potential to reduce head trialing and the associated surgical time.

"Traditional computer navigation is constrained by the time, effort, and learning curve associated with hardware insertion," said Andrew J. Cooper, M.D., Chief Medical Officer of JointPoint and a practicing orthopaedic surgeon specializing in minimally invasive hip replacement. "JointPoint has the potential to improve outcomes by providing the same data using only intraoperative imaging."

JointPoint also provides mobile preoperative digital templating for both hips and knees through the use of an iPad, and intraoperative templating for posterior approach hip replacements.

JointPoint was advised by Michelle McDonough of Musculoskeletal Clinical Regulatory Advisors ("MCRA") for their FDA clearance.

JointPoint, Inc. develops and markets software-driven medical technology for orthopaedics. The JointPoint™ software solution and OneTrial™ technology is a completely non-invasive navigation system for hip replacement surgery that provides intraoperative data and guides component selection while also optimizing efficiency within a surgical workflow. For more information, visit https://www.jointpoint.com

Events

American Association of Hip and Knee Surgeons, Dallas, Texas

JointPoint will be attending the American Association of Hip and Knee Surgeons in Dallas, Texas

Florida Orthopaedic Society Annual Meeting, Key Largo, Florida

JointPoint will be attending the Florida Orthopaedic Society Annual Meeting in Key Largo, Florida

American Academy of Orthopedic Surgeons, San Diego, California

Visit JointPoint at the annual meeting of the American Academy of Orthopedic Surgeons at booth 3651